臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jeng y m"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 96-120 / 936 (共38頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-02-21T02:04:35Z	Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma	Hsu C.-L.; Ou D.-L.; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; ANN-LII CHENG; Jeng Y.-M.; Hsu C.
臺大學術典藏	2022-02-21T02:04:34Z	Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma	Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; Hsu C.-H.; Hsu H.-C.; ANN-LII CHENG; Lin Z.-Z.
臺大學術典藏	2022-02-18T08:46:54Z	Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma	Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; CHIEN-CHUAN CHEN; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; Liau J.-Y.; Jeng Y.-M.
臺大學術典藏	2022-02-18T06:49:23Z	Rapid Trio Exome Sequencing for Autosomal Recessive Renal Tubular Dysgenesis in Recurrent Oligohydramnios	Lin S.-Y.; Chuang G.-T.; Hung C.-H.; Lin W.-C.; Jeng Y.-M.; Yen T.-A.; Chang K.; Chien Y.-H.; WUH-LIANG HWU; Lee C.-N.; Tsai I.-J.; Lee N.-C.
臺大學術典藏	2022-02-16T03:16:57Z	Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma	YU-YUN SHAO; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; Hsu C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏	2022-02-16T03:16:56Z	Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy	Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; Hsu C.-H.; Lin Z.-Z.; YU-YUN SHAO; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L.
臺大學術典藏	2022-02-15T06:22:43Z	Invasive Pathobionts Contribute to Colon Cancer Initiation by Counterbalancing Epithelial Antimicrobial Responses	LINDA CHIA-HUI YU; Wei S.-C.; Li Y.-H.; Lin P.-Y.; Chang X.-Y.; Weng J.-P.; Shue Y.-W.; Liang-Chuan Lai; Wang J.-T.; Jeng Y.-M.; Ni Y.-H.
臺大學術典藏	2022-02-14T07:10:48Z	Molecular features of primary hepatic undifferentiated carcinoma	JIA-HUEI TSAI; Jeng Y.-M.; Lee C.-H.; Liau J.-Y.
臺大學術典藏	2022-02-14T07:10:47Z	Lymphoepithelioma-like Intrahepatic Cholangiocarcinoma Is a Distinct Entity with Frequent pTERT / TP53 Mutations and Comprises 2 Subgroups Based on Epstein-Barr Virus Infection	JIA-HUEI TSAI; Liau J.-Y.; Lee C.-H.; Jeng Y.-M.
臺大學術典藏	2022-02-08T06:27:19Z	Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma	Hsu C.-L.; DA-LIANG OU; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; Cheng A.-L.; Jeng Y.-M.; Hsu C.
臺大學術典藏	2022-02-07T03:29:05Z	Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma	Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; Hsu C.; CHIH-HUNG HSU; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏	2022-02-07T03:29:03Z	Limited predictive or prognostic role of tumor-infiltrating tissue-resident memory cd8 t cells in patients with hepatocellular carcinoma receiving immunotherapy	Shen Y.-C.; Yeh C.-P.; Jeng Y.-M.; Hsu C.; CHIH-HUNG HSU; Lin Z.-Z.; Shao Y.-Y.; Lu L.-C.; Liu T.-H.; Chen C.-H.; Cheng A.-L.
臺大學術典藏	2022-01-25T05:10:47Z	Interferon-�\ reduces insulin resistance and �]-cell secretion in responders among patients with chronic hepatitis B and C	Tai T.-Y.; Lu J.-Y.; CHI-LING CHEN; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Lee C.-Z.; Lee H.-S.; Chuang L.-M.; Jeng Y.-M.
臺大學術典藏	2022-01-25T05:10:37Z	Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B	Liu C.-J.; Jeng Y.-M.; CHI-LING CHEN; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2022-01-25T03:25:06Z	Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B	Huang S.-F.; Chang I.-C.; Hong C.-C.; Yen T.-C.; CHI-LING CHEN; Wu C.-C.; Tsai C.-C.; Ho M.-C.; Lee W.-C.; Yu H.-C.; Shen Y.-Y.; Eng H.-L.; Wang J.; Tseng H.-H.; Jeng Y.-M.; Yeh C.-T.; Chen C.-L.; Chen P.-J.; Liaw Y.-F.
臺大學術典藏	2022-01-24T09:32:26Z	Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients	CHUN-JEN LIU; Chen P.-J.; Lai M.-Y.; Kao J.-H.; Jeng Y.-M.; Chen D.-S.
臺大學術典藏	2022-01-24T09:32:22Z	Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C	CHUN-JEN LIU; Jeng Y.-M.; Chen P.-J.; Lai M.-Y.; Yang H.-C.; Huang W.-L.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2022-01-24T09:32:20Z	Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C	CHUN-JEN LIU; Chen P.-J.; Jeng Y.-M.; Huang W.-L.; Yang W.-S.; Lai M.-Y.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2022-01-24T09:32:01Z	Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B	CHUN-JEN LIU; Jeng Y.-M.; Chen C.-L.; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2022-01-24T09:31:43Z	Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy	Su T.-H.; CHUN-JEN LIU; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2022-01-24T09:31:35Z	Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition	Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; CHUN-JEN LIU; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2022-01-24T09:31:31Z	Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model	Li Y.-T.; CHUN-JEN LIU; Su T.-H.; Cheng H.-R.; Jeng Y.-M.; Lin H.-L.; Wang C.-C.; Kao J.-H.; Chen P.-J.; Chen D.-S.; Wu H.-L.
臺大學術典藏	2022-01-24T06:05:35Z	Eg5 as a prognostic biomarker and potential therapeutic target for hepatocellular carcinoma	Shao Y.-Y.; Sun N.-Y.; Jeng Y.-M.; Wu Y.-M.; CHIUN HSU; Hsieh C.-H.; Hsu H.-C.; Cheng A.-L.; Lin Z.-Z.
臺大學術典藏	2022-01-20T07:58:02Z	The prognostic roles of and correlation between ALK and MYCN protein expression in neuroblastoma	Chang H.-H.; Lu M.-Y.; Yang Y.-L.; SHU-WEI CHOU; Lin D.-T.; Lin K.-H.; Hsu W.-M.; Jeng Y.-M.; Jou S.-T.
臺大學術典藏	2022-01-20T07:58:01Z	MYCN RNA levels determined by quantitative in situ hybridization is better than MYCN gene dosages in predicting the prognosis of neuroblastoma patients	Chang H.-H.; Tseng Y.-F.; Lu M.-Y.; Yang Y.-L.; SHU-WEI CHOU; Lin D.-T.; Lin K.-H.; Jou S.-T.; Hsu W.-M.; Jeng Y.-M.

顯示項目 96-120 / 936 (共38頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51783694 線上人數 : 1032 教育部委託研究計畫計畫執行:國立臺灣大學圖書館